MannKind Corporation

MNKD· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$3.80-2.81%

2026-08-03

Financials

Valuation Metrics

MannKind Corporation's Market Cap is $1.17B. At end of 2025 it was $1.73B. Ranked #2413 of 3,112 in US market (top 78%), #971 of 1,445 on NASDAQ (top 67%), #182 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 68%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.17B	US#2,413/3,112 Sec#182/269
Revenue	$361M	US#2,475/3,112 Sec#92/269
Net Income	$-24M	US—/3,112 Sec—/269
Total Assets	$744M	US#2,570/3,112 Sec#116/269
Net Assets	$-59M	US#3,012/3,112 Sec#264/269
Value
P/S	3.25x	US#1,854/3,112 Sec#51/269
EV/EBITDA	56.54x	US#2,374/3,112 Sec#81/269
FCF Yield	1.08%	US#2,128/3,112 Sec#75/269
Profitability
ROA	-3.21%	US#2,447/3,112 Sec#88/269
Op. Margin	3.71%	US#2,182/3,112 Sec#76/269
Revenue Growth	15.08%	US#967/3,112 Sec#82/269
Earnings Growth	-226.30%	US#2,245/3,112 Sec#82/269
Financial Health
Total Debt	$437M	US#1,878/3,112 Sec#61/269
FCF	$13M	US#2,195/3,112 Sec#81/269
Cash	$53M	US#2,557/3,112 Sec#224/269
Current Ratio	1.87x	US#1,337/3,112 Sec#233/269
Net Debt/EBITDA	13.93x	US#2,432/3,112 Sec#91/269
Performance
1Y Return	1.33%	US#2,170/3,112 Sec#199/269
1M Return	-15.93%	US#2,844/3,112 Sec#211/269
From 52W High	-41.63%	US#2,585/3,112 Sec#199/269
1Y MDD	-63.28%	US#2,797/3,112 Sec#226/269
Trading
Volume	5,165,143 shares	US#355/3,112 Sec#25/269
Trading Value	$20M	US#1,967/3,112 Sec#148/269
Per Share
EPS	$0.02	US#2,059/3,112 Sec#75/269